Log in

ASX:CTECryosite Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume418 shs
Average VolumeN/A
Market Capitalization$2.81 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cryosite Limited provides long term storage and supply chain logistics management of pharmaceutical products used in clinical trials and biological materials in Australia. It operates in two segments, Cord Blood and Tissues Storage, and Clinical Trials Logistics and Biorepository. The Cord Blood and Tissues Storage segment provides long term storage for cord blood and tissue samples. The Clinical Trials Logistics and Biorepository segment offers biorepository services; clinical trials logistics; commercial drug distribution; and other storage and distribution based services, including the importation and distribution of laboratory diagnostic products. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was founded in 1999 and is based in South Granville, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 8865 2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.14 million
Book ValueA($0.01) per share

Profitability

Miscellaneous

Employees23
Market Cap$2.81 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CTE News and Ratings via Email

Sign-up to receive the latest news and ratings for CTE and its competitors with MarketBeat's FREE daily newsletter.


Cryosite (ASX:CTE) Frequently Asked Questions

Has Cryosite been receiving favorable news coverage?

Media stories about CTE stock have been trending very negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cryosite earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutCryosite.

Who are some of Cryosite's key competitors?

Who are Cryosite's key executives?

Cryosite's management team includes the following people:
  • Mr. Bryan Dulhunty BEc, ACA, Exec. Chairman & Company Sec.
  • Mr. Mark Edmund Payton Byrne, Chief Exec. Officer

What is Cryosite's stock symbol?

Cryosite trades on the ASX under the ticker symbol "CTE."

How big of a company is Cryosite?

Cryosite has a market capitalization of $0.00 and generates $8.14 million in revenue each year. Cryosite employs 23 workers across the globe. View additional information about Cryosite.

What is Cryosite's official website?

The official website for Cryosite is http://www.cryosite.com/.

How can I contact Cryosite?

The company can be reached via phone at 61 2 8865 2000.

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel